Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders
Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by leveraging generative chemistry design... Read more.
Ping Identity Marks Digital Trust Milestone with Zero-Knowledge Biometrics in the Age of AI
Completion of the Keyless acquisition adds privacy-preserving biometric authentication andre-verification to strengthen enterprise defenses against AI-powered spoofing... Read more.
eInfochips Named “IoT Development Service Provider of the Year” at 2026 IoT Breakthrough Awards
SAN JOSE, Calif. and EINDHOVEN, Netherlands, Jan. 7, 2026 /PRNewswire/ — eInfochips, an Arrow Electronics company and a leading provider of engineering research... Read more.
Bayer and Cradle enter collaboration to enhance AI-enabled antibody discovery and optimization
Cradle provides a scientific AI software platform focused on protein engineering Bayer continues to utilize AI in R&D, reinforcing commitment to modernize and... Read more.
Nanoscope Therapeutics Granted New U.S. Patent Covering Its Proprietary Multi-Characteristic Opsin Platform for Vision Restoration
DALLAS, Jan. 7, 2026 /PRNewswire/ — Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic... Read more.
Aprio Expands in Pacific Northwest, Uniting Two Leading Oregon Firms – Delap LLP and Hoffman, Stewart & Schmidt, P.C.
ATLANTA and PORTLAND, Ore., Jan. 7, 2026 /PRNewswire/ — Aprio, the 24th largest business advisory and accounting firm in the U.S., announced today its entry... Read more.
Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL
JERUSALEM, Jan. 7, 2026 /PRNewswire/ — Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI); (“Scinai”, or the “Company”), a biopharmaceutical... Read more.
Accurus Aerospace Appoints Dan Murphy as Chief Executive Officer
Proven Aerospace Industry Executive to Execute Next Phase of Strategic Growth Plan TULSA, Okla., Jan. 7, 2026 /PRNewswire/ — Accurus Aerospace Holdings, LLC... Read more.
Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer
Experienced Industry Leader with More than Two Decades of Global Commercialization and Marketing Expertise SAN DIEGO, Jan. 7, 2026 /PRNewswire/ — Viking Therapeutics,... Read more.
AL-S Pharma to present at the upcoming J. P. Morgan 2026 Annual Healthcare Conference on Thursday, January 15
ZURICH, Jan. 7, 2026 /PRNewswire/ — AL-S Pharma AG, a Swiss-based, single-asset clinical-stage biopharmaceutical company founded and co-owned by Neurimmune... Read more.